CTCL
Clinical trials for CTCL explained in plain language.
Never miss a new study
Get alerted when new CTCL trials appear
Sign up with your email to follow new studies for CTCL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for Tough-to-Treat skin cancer: PTX-100 trial launches
Disease control Recruiting nowThis study tests a new drug called PTX-100 in people with a rare type of skin lymphoma (CTCL) that has come back or not responded to other treatments. About 115 adults will receive the drug through an IV for several cycles. The goal is to see if it can shrink or control the cance…
Matched conditions: CTCL
Phase: PHASE2 • Sponsor: Prescient Therapeutics, Ltd. • Aim: Disease control
Last updated May 17, 2026 03:57 UTC
-
Light-Activated gel shows promise against rare skin cancer
Disease control Recruiting nowThis study tests a gel called HyBryte, which is activated by visible light, to treat a rare type of skin lymphoma (CTCL). About 80 adults with early-stage disease will apply the gel to their skin lesions and then receive light treatment. The goal is to see if the gel can shrink o…
Matched conditions: CTCL
Phase: PHASE3 • Sponsor: Soligenix • Aim: Disease control
Last updated May 11, 2026 20:40 UTC
-
New gel could replace steroids for itchy skin in cancer patients
Symptom relief Recruiting nowThis study tests if a gel called StrataCTX can help reduce itching and the need for steroid creams in people with skin reactions from CTCL or chemotherapy. About 70 adults will use the gel alongside their usual care. The goal is to see if it improves quality of life and controls …
Matched conditions: CTCL
Phase: NA • Sponsor: Columbia University • Aim: Symptom relief
Last updated May 15, 2026 11:56 UTC